Richard M. Goldberg, MD, FASCO discusses outcomes of the phase 3 CALGB/SWOG 80405 study
Richard M. Goldberg, MD, FASCO, Physician-in-Chief at Ohio State University Comprehensive Cancer Center, discusses outcomes of the phase 3 CALGB/SWOG 80405 study regarding primary site of tumor